Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

LY 288513

Known as: LY288513 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
SummaryCholecystokinin (CCK) is one of the most abundant neuropeptides in the brain. It is found in the highest levels in… 
  • table I
  • table II
1996
1996
The potency and specificity of five proposed cholecystokinin-B receptor antagonists, YM022, RP73870, L-740,093, L-365,260 and… 
1996
1996
IN order to explore the potential clinical utility of CCK-B antagonists for the treatment of nicotine withdrawal symptoms, the… 
1994
1994
In humans, withdrawal from the chronic use of benzodiazepines can result in a variety of undesirable side effects, including… 
Highly Cited
1993
Highly Cited
1993
The diphenylpyrazolidinone cholecystokinin (CCK)-B antagonist LY262691 has recently been demonstrated to decrease the number of… 
1993
1993
In order to explore the potential clinical utility of CCK-B antagonists for the treatment of benzodiazepine withdrawal symptoms…